Kosuke Ebina

3.7k total citations
131 papers, 2.5k citations indexed

About

Kosuke Ebina is a scholar working on Rheumatology, Orthopedics and Sports Medicine and Oncology. According to data from OpenAlex, Kosuke Ebina has authored 131 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Rheumatology, 59 papers in Orthopedics and Sports Medicine and 28 papers in Oncology. Recurrent topics in Kosuke Ebina's work include Rheumatoid Arthritis Research and Therapies (39 papers), Foot and Ankle Surgery (29 papers) and Bone Metabolism and Diseases (23 papers). Kosuke Ebina is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (39 papers), Foot and Ankle Surgery (29 papers) and Bone Metabolism and Diseases (23 papers). Kosuke Ebina collaborates with scholars based in Japan, United States and Canada. Kosuke Ebina's co-authors include Makoto Hirao, Jun Hashimoto, Hideki Yoshikawa, Shoichi Kaneshiro, Kenrin Shi, Tokimitsu Morimoto, Kota Koizumi, Takaaki Noguchi, Yoshitaka Kawato and Masafumi Kashii and has published in prestigious journals such as Nature Immunology, PLoS ONE and Journal of Bone and Joint Surgery.

In The Last Decade

Kosuke Ebina

122 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kosuke Ebina Japan	26	848	683	679	458	297	131	2.5k
Makoto Hirao Japan	28	934 1.1×	705 1.0×	726 1.1×	432 0.9×	251 0.8×	114	2.8k
Tatsuya Koike Japan	31	1.4k 1.6×	288 0.4×	891 1.3×	334 0.7×	279 0.9×	136	3.5k
Kenrin Shi Japan	19	371 0.4×	170 0.2×	397 0.6×	436 1.0×	505 1.7×	44	1.9k
Joseph Caverzasio Switzerland	40	658 0.8×	503 0.7×	2.3k 3.4×	1.0k 2.2×	133 0.4×	120	4.4k
Yaping Ye China	31	303 0.4×	170 0.2×	1.5k 2.1×	370 0.8×	146 0.5×	85	2.8k
Eric T. Everett United States	28	696 0.8×	80 0.1×	901 1.3×	249 0.5×	217 0.7×	72	2.7k
Takao Fujii Japan	31	800 0.9×	67 0.1×	573 0.8×	187 0.4×	433 1.5×	144	3.4k
Zhongmin Zhang China	29	351 0.4×	189 0.3×	1.1k 1.6×	364 0.8×	119 0.4×	149	2.6k
Dominique Modrowski France	32	408 0.5×	603 0.9×	1.4k 2.1×	616 1.3×	80 0.3×	59	2.9k
M.C. de Vernejoul France	40	403 0.5×	2.4k 3.5×	1.8k 2.7×	1.7k 3.7×	164 0.6×	134	5.3k

Countries citing papers authored by Kosuke Ebina

Since Specialization

Citations

This map shows the geographic impact of Kosuke Ebina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosuke Ebina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosuke Ebina more than expected).

Fields of papers citing papers by Kosuke Ebina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kosuke Ebina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosuke Ebina. The network helps show where Kosuke Ebina may publish in the future.

Co-authorship network of co-authors of Kosuke Ebina

This figure shows the co-authorship network connecting the top 25 collaborators of Kosuke Ebina. A scholar is included among the top collaborators of Kosuke Ebina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kosuke Ebina. Kosuke Ebina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ebina, Kosuke, Tomonori Kobayakawa, Yuki Etani, et al.. (2025). Impact of prior teriparatide treatment on the effectiveness of romosozumab in patients with postmenopausal osteoporosis: A case-control study. Bone. 193. 117389–117389. 2 indexed citations

Shimamura, Munehisa, Yuki Etani, Takaaki Noguchi, et al.. (2025). Receptor activator of nuclear factor-kappa B ligand-derived microglia healing peptide 1-AcN inhibits osteoarthritis progression in mice. Arthritis Research & Therapy. 27(1). 142–142. 1 indexed citations

Etani, Yuki, Takaaki Noguchi, Tomonori Kobayakawa, et al.. (2025). Impact of baseline PINP on the BMD increase with romosozumab, teriparatide, and denosumab in treatment-naïve primary osteoporosis: A retrospective cohort study. Bone. 201. 117627–117627. 1 indexed citations

Ebina, Kosuke, Yuki Etani, Takaaki Noguchi, Ken Nakata, & Seiji Okada. (2024). Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis. Journal of Bone and Mineral Metabolism. 43(1). 3–9. 13 indexed citations

Ebina, Kosuke, Masafumi Kashii, Hideki Tsuboi, et al.. (2024). An investigation of the differential therapeutic effects of romosozumab on postmenopausal osteoporosis patients with or without rheumatoid arthritis complications: a case–control study. Osteoporosis International. 35(5). 841–849. 6 indexed citations

Okamura, Gensuke, Makoto Hirao, Takaaki Noguchi, et al.. (2024). Flatfoot Surgery for Flexible Progressive Collapsing Foot Deformity With Inflammatory Joint Diseases. JBJS Case Connector. 14(3).

Noguchi, Takaaki, Makoto Hirao, Kosuke Ebina, et al.. (2024). Modified scarf osteotomy has a possible capability to be indicated against very severe hallux valgus deformity. BMC Musculoskeletal Disorders. 25(1). 977–977.

Etani, Yuki, Makoto Hirao, Satoshi Yamakawa, et al.. (2023). Basic fibroblast growth factor promotes meniscus regeneration through the cultivation of synovial mesenchymal stem cells via the CXCL6–CXCR2 pathway. Osteoarthritis and Cartilage. 31(12). 1581–1593. 11 indexed citations

Nakayama, Yoichi, Ryu Watanabe, Wataru Yamamoto, et al.. (2023). IL-6 inhibitors and JAK inhibitors as favourable treatment options for patients with anaemia and rheumatoid arthritis: ANSWER cohort study. Lara D. Veeken. 63(2). 349–357. 5 indexed citations

10.

Ebina, Kosuke, Tôru Hirano, Yuichi Maeda, et al.. (2021). Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study. Clinical Rheumatology. 40(7). 2673–2680. 16 indexed citations

11.

Jinno, Sadao, Akira Ōnishi, Maureen Dubreuil, et al.. (2021). Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis—the ANSWER cohort study. Arthritis Research & Therapy. 23(1). 116–116. 12 indexed citations

12.

Maeda, Yuichi, Tôru Hirano, Kosuke Ebina, et al.. (2021). Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study. Rheumatology International. 41(7). 1233–1241. 1 indexed citations

13.

Maeda, Yuichi, Tôru Hirano, Ryota Hara, et al.. (2020). THU0174 ANTI-IL-6 RECEPTOR ANTIBODY AMELIORATES DISEASE ACTIVITY OF RHEUMATOID ARTHRITIS PATIENTS WITH KNEE JOINT INVOLVEMENT -ANSWER COHORT STUDY-. Annals of the Rheumatic Diseases. 79. 302–303. 1 indexed citations

14.

Ebina, Kosuke, Tôru Hirano, Yuichi Maeda, et al.. (2020). Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study-. Clinical Rheumatology. 39(9). 2563–2572. 14 indexed citations

15.

Jinno, Sadao, Akira Ōnishi, Maureen Dubreuil, et al.. (2020). Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort study. Rheumatology International. 40(12). 1987–1995. 15 indexed citations

16.

Hasegawa, Tetsuo, Junichi Kikuta, Takao Sudo, et al.. (2019). Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1. Nature Immunology. 20(12). 1631–1643. 144 indexed citations

17.

Murata, Koichi, Motomu Hashimoto, Wataru Yamamoto, et al.. (2019). The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study. Rheumatology International. 40(2). 217–225. 6 indexed citations

18.

Hashimoto, Motomu, Moritoshi Furu, Ryota Hara, et al.. (2018). Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study. Arthritis Research & Therapy. 20(1). 165–165. 21 indexed citations

19.

Kashii, Masafumi, Kosuke Ebina, Takashi Kaito, et al.. (2017). Effects of single or combination therapy of teriparatide and anti-RANKL monoclonal antibody on bone defect regeneration in mice. Bone. 106. 1–10. 18 indexed citations

20.

Chijimatsu, Ryota, Makoto Ikeya, Yukihiko Yasui, et al.. (2017). Characterization of Mesenchymal Stem Cell-Like Cells Derived From Human iPSCs via Neural Crest Development and Their Application for Osteochondral Repair. Stem Cells International. 2017. 1–18. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact